NL-OMON45146已完成不适用
Sedation with propofol TCI during ERCP: Is the combination with esketamine more effective and safer than with alfentanil (SPEKA): A randomized controlled multicentre trial - SPEKA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 166
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •The patients must comply with the following criteria in order to be eligible to participate in this clinical study:;Age range * 18 years
- •ASA classification I * III
- •Planned ERCP/EUS procedure
- •Written informed consent
排除标准
- •Patient will be excluded if the following criteria are applicable:
- •Age range< 18 years
- •ASA classification IV and V
- •Allergic reaction to planned medication in the patients* medical history
- •Unregulated hypertension
- •History of malignant hypertension
- •Significant ischaemic heart disease
- •Mentally disordered
- •History of psychological problems or psychiatric disease
- •Use of drugs that affect the central nervous system
- •Substance abuse
- •Chronic pain
- •Seizure disorders
- •Increased intracranial pressure
研究者
相似试验
已完成
不适用
Comparison of different forms of sedation during endoscopie of the bile ductsNL-OMON22136Department of Anesthesiology and , Department of Gastroenterology & Hepatology, Academic Medical Centre,166
进行中（未招募）
不适用
Comparison of two forms of sedation during endoscopic inspection of the liver and bile ductsPatients undergoing ERCPs under propofol sedation combined with ketamine or alfentanil given by trained anesthesia nurse.EUCTR2015-002667-42-NLAMC
进行中（未招募）
不适用
Patient-controlled sedation with propofol in ERCP:alfentanyl vs remifentanylBilliar tract and pancreatic disoderesMedDRA version: 9.1Level: LLTClassification code 10004676Term: Biliary tract diseaseMedDRA version: 9.1Level: LLTClassification code 10004677Term: Biliary tract disorder NOSMedDRA version: 9.1Level: LLTClassification code 10033616Term: Pancreatic disorderEUCTR2009-012398-36-FIHelsinki University Hospital75
尚未招募
不适用
Comparison of two anaesthetic drug as sedative for ERCPCTRI/2022/07/043892itin mantri
Unknown
不适用
Efficacy and Safety Profile of Remimazolam-alfentanil Combination for ERCP SedationAnesthesiaNCT04658173Tianjin Nankai Hospital1,000